Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

VELOXIS PHARMACEUTICALS, INC

Subsidiary ofASAHI KASEI CORPORATIONUEI: YJQMS7XCLTM7CAGE: 79YG9

VELOXIS PHARMACEUTICALS, INC is a federal contractor, registered under UEI YJQMS7XCLTM7 and CAGE code 79YG9. It has been awarded $820,083 in federal contracts. Primary work spans Pharmaceutical Preparation Manufacturing. Top awarding agencies include Department Of Veterans Affairs and Other agencies (1 agencies, <0.5% each).

Contact Information

Registration and classification details

Registration

UEI Code

YJQMS7XCLTM7

CAGE Code

79YG9

Entity Structure

Corporate Entity (Not Tax Exempt)

Established

N/A

Business Classifications

For Profit OrganizationForeign OwnedManufacturer of Goods

NAICS Codes

325412Pharmaceutical Preparation Manufacturing(Primary)

Federal Contracting Overview

Award totals, agency breakdown, NAICS distribution, and geographic footprint.

AI Capability Profile

Veloxis Pharmaceuticals, Inc. specializes in the manufacturing of pharmaceutical preparations, with a focused expertise in the development and production of complex drug formulations, including those used in hematology and specialty therapeutic areas. The company leverages advanced pharmaceutical ma...

Veloxis Pharmaceuticals, Inc. specializes in the manufacturing of pharmaceutical preparations, with a focused expertise in the development and production of complex drug formulations, including those used in hematology and specialty therapeutic areas. The company leverages advanced pharmaceutical manufacturing processes to produce active pharmaceutical ingredients and finished dosage forms that meet stringent FDA and federal regulatory standards. Their technical capabilities encompass solid dosage manufacturing, drug stability testing, and quality control systems aligned with cGMP requirements, ensuring consistent product integrity for mission-critical medical applications. Veloxis differentiates itself through precision formulation science and scalable production workflows tailored to meet the demands of government healthcare programs requiring reliable, high-quality pharmaceutical supply chains. The company maintains a direct contracting relationship with the Department of Veterans Affairs, supplying pharmaceutical products under the Federal Supply Schedule for drugs, hematology-related therapeutics, and other essential medications used in veteran care. This engagement reflects a trusted partnership in delivering clinically validated, on-demand pharmaceuticals to VA medical facilities nationwide. Veloxis operates primarily within NAICS 325412, which encompasses the manufacturing of finished pharmaceutical products, including tablets, capsules, and injectables. Their market positioning centers on specialty pharmaceuticals with therapeutic relevance to chronic and hematologic conditions, serving federal healthcare systems that require secure, compliant, and consistent drug sourcing. As a small business structured as a 2L entity based in Cary, North Carolina, Veloxis Pharmaceuticals maintains a focused operational footprint with no federal certifications on record. The company’s government market presence is anchored in its ability to deliver regulated pharmaceutical products directly to federal medical providers, positioning it as a niche supplier within the VA’s pharmaceutical procurement ecosystem.

Key Performance Metrics

Awards Count

4

All time

Active

0

Currently performing

Completed

4

Past period of performance

Total Awards

All time

Contracts

Prime · all time

Subcontracts

Sub · all time

Grants

Prime · all time

Subgrants

Sub · all time

Award Analytics & Distribution

Awards by Agency
Department Of Veterans Affairs$820.0K100%
Other agencies (1 agencies, <0.5% each)$82.70%
Awards by NAICS
Awards by Agency Over Time
Awards by Place of Performance

Compete with VELOXIS PHARMACEUTICALS, INC

Track the contractors you bid against, and the work they win

Award history, agency mix, and NAICS coverage for VELOXIS PHARMACEUTICALS, INC

AI-powered matching against your own capabilities and past performance

Teaming and subcontracting signals on every award

Automated alerts when a competitor wins in your market

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS

Open opportunities in VELOXIS PHARMACEUTICALS, INC's top NAICS codes and agencies

NAICS: 561990
New
Federal
Intent to Sole Source Fire Suppression and Emergency Response Service
Solicitation # 36C26326Q0635_1
The Department of Veterans Affairs, Network Contracting Office 23, intends to award a sole source contract to the City of Minneapolis for fire suppression and emergency response services at the Veterans Affairs Medical Center in Minneapolis, Minnesota, including buildings at Fort Snelling. This action is being taken under the authority of FAR 6.103-1 and FAR 12.102(a), as the government has determined that only one responsible source can satisfy the agency requirements. The contractor is required to provide 24/7 contractor owned and contractor operated services, including responses to fire alarms, hazardous material spills, confined space rescues, and elevator entrapments. Key performance requirements include maintaining a minimum of four certified professional firefighters and two fire pumper apparatus with at least 1200 gpm capacity, ensuring a maximum response time of eight minutes to any location on the campus. The contractor must adhere to NFPA, IFC, OSHA, and State of Minnesota standards, maintain a minimum ISO rating of 3, and hold mutual aid agreements with at least two other municipal fire departments. Deliverables include annual building inspections, a phase-in plan due within ten days of award, and a confined space rescue plan due within fourteen days of the notice of award. Interested parties wishing to challenge the sole source determination must submit a capabilities statement by October 23, 2026.
Department Of Veterans Affairs

POSTED

about 15 hours ago

DEADLINE

in 8 days
View Details
NAICS: 325412
New
DIBBS
POVIDONE-IODINE CLEANS
Solicitation # SPE2DP-27-T-0111
Solicitation SPE2DP-27-T-0111 is a procurement request by the Defense Logistics Agency for five one-gallon bottles of USP Povidone-Iodine Cleansing Solution with a 7.5% active ingredient for external use. The product, identified by NSN 6505009947224, must have a total shelf life of 36 months, with at least 31 months remaining upon delivery to the first government activity. Storage requirements specify a temperature of 25 degrees Fahrenheit, with permitted excursions between 15 and 30 degrees Celsius. The items are to be delivered FOB Destination to the USS PRINCETON CG 59 with a required delivery date of October 16, 2026, and a delivery window of five days after receipt of order. The contract mandates strict adherence to medical marking and packaging standards, specifically Medical Marking Standard No. 1, which supersedes MIL-STD-129. Packaging must be commercial and capable of protecting contents from damage, with palletization following DLA requirement RP001. Because the material may be hazardous, suppliers must comply with OSHA Hazard Communication Standards, providing Safety Data Sheets and HCS labels for review prior to award. Administrative requirements include the use of Wide Area WorkFlow for invoicing and compliance with various FAR and DFARS clauses regarding cybersecurity, basic safeguarding of contractor information systems, and domestic sourcing restrictions such as the Buy American Act and the Berry Amendment.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

1 day ago

DEADLINE

in 5 days
View Details